Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Lung Cancer Congress (ELCC 2023) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.

ELCC 2023

European Lung Cancer Congress 2023
29 Mar–01 April 2023 | Copenhagen, Denmark

ELCC 2023

European Lung Cancer Congress 2023
29 Mar–01 April 2023 | Copenhagen, Denmark
The European Lung Cancer Congress (ELCC 2023) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.
Liquid biopsies as a diagnostic tool in patients with lung cancer 2:13
Liquid biopsies as a diagnostic tool in patients with lung cancer
Klaus Pantel • 30 Mar 2023
Managing low-grade immunotherapy-associated toxicity in lung cancer 1:33
Managing low-grade immunotherapy-associated toxicity in lung cancer
Milica Kontic Jovanovic • 27 Mar 2023
What is the risk of pneumonitis in patients with pulmonary fibrosis treated with ICIs? 2:36
What is the risk of pneumonitis in patients with pulmonary fibrosis treated with ICIs?
Milica Kontic Jovanovic • 27 Mar 2023
Anticipations for ELCC 2023 0:25
Anticipations for ELCC 2023
Milica Kontic Jovanovic • 27 Mar 2023
POET: the predictive and prognostic value of PD-L1 expression in NSCLC 1:21
POET: the predictive and prognostic value of PD-L1 expression in NSCLC
Lorenzo Belluomini • 4 Apr 2023
POET: findings and clinical implications for NSCLC prognosis 1:59
POET: findings and clinical implications for NSCLC prognosis
Lorenzo Belluomini • 4 Apr 2023
Stereotactic radiotherapy vs surgery in early-stage NCSLC 2:18
Stereotactic radiotherapy vs surgery in early-stage NCSLC
Paul Van Schil • 3 Apr 2023
Lymph node resection and staging as unmet needs in thoracic surgery 2:09
Lymph node resection and staging as unmet needs in thoracic surgery
Paul Van Schil • 3 Apr 2023
Multimodality treatment and alternative endpoints in lung cancer at ELCC 2023 1:43
Multimodality treatment and alternative endpoints in lung cancer at ELCC 2023
Paul Van Schil • 4 Apr 2023
Practical considerations for the use of liquid biopsies in lung cancer 1:32
Practical considerations for the use of liquid biopsies in lung cancer
Klaus Pantel • 27 Mar 2023
ELCC 2023: novel lung cancer treatment strategies 4:13
ELCC 2023: novel lung cancer treatment strategies
Jessica Menis • 31 Mar 2023
Amivantamab in patients with EGFR Ex20ins-mutated NSCLC 2:28
Amivantamab in patients with EGFR Ex20ins-mutated NSCLC
Pilar Garrido Lopez • 30 Mar 2023
Highlights from ELCC 2023 in lung cancer 1:04
Highlights from ELCC 2023 in lung cancer
Pilar Garrido Lopez • 30 Mar 2023
Practical considerations for molecular profiling in NSCLC 1:38
Practical considerations for molecular profiling in NSCLC
Pilar Garrido Lopez • 30 Mar 2023
Liquid biopsy highlights from ELCC 2023 0:54
Liquid biopsy highlights from ELCC 2023
Umberto Malapelle • 27 Mar 2023
Current and future approaches of immunotherapy for NSCLC 1:04
Current and future approaches of immunotherapy for NSCLC
Ana Laura Ortega Granados • 31 Mar 2023
The content of VJOncology is intended for healthcare professionals